How can we best foster pharmaceutical science innovation and its translation into the clinic? The current COVID-19 pandemic is an opportunity for pharmaceutical scientists to reflect on the traditional models for ...
Over the past decade our understanding of the host-microbiota interactions has burgeoned. The human intestinal microbiota intrinsically contributes to energy production, metabolism and immunity with a gene set 100 ...
E5 Innovations in vaccines to counter emerging global health threats
Vaccines have been our weapon against some of the deadliest infectious diseases in the world. They protect at individual as well as community level, providing an inherent societal benefit and have played a major role in ...
C4 Genomics: Realising its full potential in clinical practice
Pharmacogenomics and precision medicine offer great promise for the treatment of a variety of diseases, from rare diseases to diseases affecting large numbers of people, such as cancer or mental illnesses. The analysis ...
D2 Joining mechanistic and epidemiological approaches to enhance causal inference of drug effects
Mechanistic studies have seen great advances in use of models and modelling to predict drug effects, but inherent in these inductive approaches are concerns about (lack of) translation into real-world situations. In ...
B4 Innovative drug delivery approaches to meet key challenges in global health
This session will highlight how innovative drug delivery systems can be developed to solve challenges in global health that affect low and middle income countries. There is a perception that solutions for challenges ...